Unresectable Thyroid Gland Carcinoma
7 clinical trials · Condition
◉ Watch Unresectable Thyroid Gland Carcinoma
| Record | Firm | Date |
|---|---|---|
| Lenvatinib and Pembrolizumab for the Treatment of Stage IVB Locally Advanced and Unresectable or Stage IVC Metastatic Anaplastic Thyroid Cancer (NCT04171622) | M.D. Anderson Cancer Center | 2021-11-04 |
| Lenvatinib and Pembrolizumab in Differentiated Thyroid Cancers (DTC) (NCT02973997) | Academic and Community Cancer Research United | 2018-02-07 |
| Atezolizumab With Chemotherapy in Treating Patients With Anaplastic or Poorly Differentiated Thyroid Cancer (NCT03181100) | M.D. Anderson Cancer Center | 2017-07-27 |
| Dabrafenib and Lapatinib in Treating Patients With Refractory Thyroid Cancer That Cannot Be Removed by Surgery (NCT01947023) | National Cancer Institute (NCI) | 2013-09-27 |
| Cediranib Maleate With or Without Lenalidomide for the Treatment of Thyroid Cancer (NCT01208051) | National Cancer Institute (NCI) | 2010-09-09 |
| Sunitinib Malate in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by Surgery (NCT00381641) | National Cancer Institute (NCI) | 2006-08-29 |
Track Unresectable Thyroid Gland Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.